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ABSTRACT: Immunization of adult male rabbits with a synthetic lutein-
izing hormone–receptor peptide (LH-RP; representing amino-acids 21–
41 of the extracellular domain of the rat LH receptor) resulted in pro-
duction of high-titer antibodies capable of interacting with particulate and
cell-based LH receptors. The antibody produced was able to inhibit bind-
ing of 125I-labeled human chorionic gonadotropin (hCG) to a particulate
sheep luteal LH receptor preparation by 40%–50%. Maximal inhibitory
activity was correlated with high antibody titer. Immunocytometry re-
vealed that the antibody could directly bind to cells having LH receptors,
such as rat granulosa and Leydig cells. The antibodies recognized a
77-kilodalton membrane protein in Western blots of mouse testicular
extracts. Interaction of endogenous Leydig cell LH receptor with the LH-
RP antibody resulted in both hormone agonist and antagonistic activi-
ties. The hormone-mimicking activity (increase in serum testosterone
over control) was confined only to the early phase of immunization when
the antibody titer was low. Blockade of LH receptor during the later part
of immunization resulted in a significant reduction in serum testosterone
over controls and inhibition of spermatogenesis. DNA flow cytometry
showed that a specific and significant inhibition of meiosis (transfor-
mation of primary spermatocytes to round and elongated spermatids P
 .01) and spermiogenesis (transformation of round spermatids to elon-
gated spermatids P  .0001) occurred following blockade of LH func-
tion.
Key words: Testicular function, spermatogenesis, receptor anti-
bodies.
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Spermatogenesis in mammals is mainly regulated by 2glycoprotein hormones; namely, follicle-stimulating
hormone (FSH) and luteinizing hormone (LH). Immuni-
zation of adult male bonnet monkeys (Macaca radiata)
with ovine FSH (Aravindan et al, 1993) as well as a re-
combinant FSH receptor protein has been shown to result
in impairment of spermatogenesis (Moudgal et al, 1997).
Immunization of male rabbits (Jeyakumar et al, 1995) and
monkeys (Suresh et al, 1995) with ovine LH also results
in blockade of testosterone production and spermatogen-
esis. Immunization of rabbits with a holo LH receptor
(LH-R) preparation isolated from sheep corpora lutea led
to the production of receptor-specific antibodies, but not
to testicular dysfunction (Jeyakumar and Moudgal, 1996).
This was shown to be due to the presence of antibodies
expressing both hormone-mimicking and antagonistic ac-
tivities throughout the period of immunization. During the
early period of immunization, when only hormone-mim-
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icking antibodies were present, there was a sustained
(lasting over several weeks) and significant (fourfold to
sevenfold) increase in serum testosterone levels. The re-
turn of serum testosterone to normal levels during later
periods of immunization could be correlated to the ap-
pearance of receptor antagonistic (blocking) antibodies.
The occurrence of both types of antibodies in the serum
could be demonstrated by in vitro tests (Jeyakumar and
Moudgal, 1996). The presence of hormone-mimicking an-
tibodies of sufficiently high titer throughout immunization
was held responsible for the lack of inhibition of serum
testosterone over control and maintenance of normal tes-
ticular function. This study suggested that the epitopic
regions of LH-R capable of generating hormone-mimick-
ing and hormone antagonistic antibodies could be differ-
ent.
The amino acid sequence of the LH receptor of a num-
ber of species has been enumerated, and peptide regions
of the extracellular domain, which could be involved in
specific binding to LH/human chorionic gonadotropin
(hCG), have been recognized (Roche et al, 1992). Two
peptides corresponding to amino acid residues 21–38 and
21–41 of the extracellular domain of the rat LH/hCG re-
ceptor exhibited significant inhibitory activity in the in
vitro 125I hCG-receptor binding assay, and region 21–38
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has been suggested to be an LH/hCG binding site (Roche
et al, 1992). Because significant inhibition could be ob-
tained with the synthetic peptide using only molar con-
centrations (IC50 9.67 to 15.4  106 M), it was believed
that obtaining corroborating evidence by other means
would be useful to ensure that these regions do indeed
represent the ligand binding site of the receptor. In the
current study, an attempt has been made to investigate
whether the antibody raised to the synthetic peptide, 21–
41, of the rat LH-R, is capable of blocking endogenous
LH activity in the male rabbit. It was believed that avail-
ability of one or more such synthetic antigens whose an-
tibody could specifically block the responsiveness of go-
nadal cells to LH could be useful in generating newer
therapeutic agents.
Materials and Methods
The Antigen
The rat LH-RP21–41, corresponding to amino acid sequence Arg-
Cys-Pro-Gly-Pro-Arg-Ala-Gly-Leu-Ala-Arg-Leu-Ser-Leu-Thr-
Tyr-Leu-Pro-Val-Lys-Val, was synthesized by the solid-phase
method, using a semiautomated LKB Biolynx 4175 peptide syn-
thesizer employing fluorenylmethoxy carbonyl (Fmoc) chemis-
try (Atherton and Sheppard, 1989). Amino acids were coupled
as 2-(1h benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluo-
rophosphate (HBTu) esters in the presence of an equivalent
amount of 1-hydroxybenzotriazole (HOBT) using diisopropyle-
thylamine as a catalyst. The peptide was cleaved from the Nova
Syn KA resin by treatment for 5 hours with a mixture of tri-
fluoroacetic acid, thioanisole, metacresol, and phenol (10:0.1:
0.05 v/v). The resulting 21–41 synthetic peptide (LH-RP) was
checked for purity by fast-performance liquid chromatography
and amino acid analysis using an LKB 4151 Alpha Plus Amino
Acid Analyzer. The LH-RP concentration of the final solution
used as the antigen was 0.44 mg/mL.
Immunization and Titration of Antibodies
Three adult male healthy rabbits bred in the laboratory (New
Zealand white) were immunized with the LH-RP conjugated
with Keyhole Limpet Hemocyanin (KLH) in the proportion of
1:500 (Briand et al, 1985). The immunization schedule consisted
of subcutaneous injections of 500 g LH-RP equivalent of the
conjugate emulsified in Freunds complete adjuvant on day 1.
The antigen was injected at several sites on the back of rabbits.
This was followed by injecting a 500 and 300 g LH-RP equiv-
alent of the conjugate in Freunds incomplete adjuvant on days
15 and 40, respectively. Booster injections (300 g) in saline
were given on days 80 and 130.
Production of antibodies to LH-RP was monitored by a stan-
dard enzyme-linked immunosorbent assay (ELISA) procedure
(Suter, 1982). To obtain a proper assessment of the specific LH-
RP antibody titer, the wells of the ELISA plate were coated with
LH-RP (100 ng/well) conjugated to a protein carrier other than
KLH. Control wells coated with the above protein carrier alone
were used to determine nonspecific antibody binding. The plates
were washed 4 times with phosphate-buffered saline (PBS) con-
taining Tween 20 (PBST) before the sites were blocked with 5%
dry milk (250 L) for 1 hour. After washing 3 times with PBST,
antiserum of different dilutions was added to the wells and in-
cubated for 2 hours at room temperature. Following further
washing with PBST, 200 L of antibody (1:600) to rabbit im-
munoglobulin (Ig) G conjugated with horseradish peroxidase
(HRP) was added to the wells and incubated for 1 hour at room
temperature. The color that developed following the addition of
orthophenylenediamine (0.03% in citric acid buffer pH 5.5) and
incubation for 10 minutes was quantitated by measuring the op-
tical density at 490 nm in an ELISA reader.
The ability of the LH-RP antibodies to block the binding of
125I-labeled hCG to particulate sheep luteal LH receptor prepa-
ration was tested primarily according to the procedure described
in detail by Jeyakumar and Moudgal (1996). In brief, this con-
sisted of incubating sheep luteal receptor preparation (1 mg/tube)
with 125I hCG (1.5–2.0  105 cpm/tube) in the presence of 100
L of normal rabbit serum (control) or antiserum to LH-RP for
2 hours (total volume, 300 L) at room temperature. To facilitate
precipitation of receptor and processing, 5% polyethylene glycol
(PEG) was added, the receptor pellet collected by centrifugation
was washed with 1 mL radioreceptor assay (RRA) buffer, and
radioactivity was monitored. Total and nonspecific binding val-
ues determined in the absence and presence of excess unlabeled
hCG were in the order of 30%–40% and 2%–6%, respectively,
of added radioactivity.
Western Blotting of LH Receptor
Adult mouse testis was extracted using a lysis buffer as de-
scribed (Babu et al, 2000) for examining the solubilized LH-Rs.
Skeletal muscle was also extracted to serve as a control. Equiv-
alent amounts of solubilized protein (25 g) was run on sodium
dodecyl sulfate–polyacrylamide gel electrophoresis and trans-
ferred to polyvinyldifluoride membranes (Polyscreen, NENTM
Life Science Products, Boston, Mass) for reaction with antibod-
ies. Following reaction with a 1:10 000 dilution of each rabbit
antibody, detection was performed by chemiluminescence using
commercial kits (ECLplus, Amersham, Buckinghamshire,
United Kingdom). Molecular weight markers were used to com-
pute the mass of the detected bands. After tests with LH-R an-
tibodies, each blot was stripped for reprobing with an actin an-
tibody (Sigma Chemical Company, St Louis, Mo) to test for
equivalent loading and transfer.
Flow Cytometric Analysis: Preparation of Single Cell
Suspension From Testicular Biopsy
The procedure used for preparing single-cell suspensions from a
testicular biopsy was essentially that as described earlier (Suresh
et al, 1992). In brief, testicular cells were released from the sem-
iniferous tubules in calcium- and magnesium-free PBS by minc-
ing the tissue obtained at biopsy with fine, curved scissors. The
tissue mince was gently aspirated to disperse the cells, washed
with PBS, and centrifuged for 10 minutes at 800  g. The pellet
was resuspended in 1 mL PBS; filtered through 100-m nylon
mesh; and the cells were fixed in chilled, 70% ethanol and stored
at 4C until further analysis (Suresh et al, 1992).
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Figure 1. Effect of LH-RP immunization of rabbits on its antibody titer.
The rabbit numbers 123, 126, and 127 are represented by symbols ,
, and H17009, respectively. The optical density (O.D.) at 490 nm of each
antiserum tested at 1:800 dilution is shown. For details of methodology
used in determining antibody titer see text.
Figure 2. Demonstrating the ability of the LH-RP antibody to bind LH-RP
21–41 (), used in current study, and LH-RP 21–38 (✖), LH-RP21–41a
(), and b (H17009), which were procured from other sources.
Propidium Iodide Staining of Testicular Cells
The ethanol-fixed cells were stained with propidium iodide (PI)
as described earlier (Suresh et al, 1992). Briefly, an aliquot of
1–2 million cells/mL was washed twice with PBS and incubated
in 300 L of 0.5% pepsin solution (prepared in 0.9% saline pH
2) for 10 minutes at 37C. After centrifugation the cells were
stained with PI staining solution (25 g/mL PI, 40 g/mL RN-
ase, and 0.3% Nonidet P-40 in PBS) for 20 minutes at room
temperature. The PI-stained cells were analyzed using a FAC-
Scan flow cytometer (Becton Dickinson, San Jose, Calif)
equipped with a 15-mw argon-ion laser at an excitation wave
length of 488 nm. The fluorescence signal of PI was collected
after being passed through a 620-bandpass filter (605–635 nm).
Preparation of Leydig Cells and Granulosa Cells for
Determining LH-RP Binding Sites
A Leydig cell–rich fraction from the testes of adult Wistar rats
was prepared according to the procedure of Van Damme et al
(1974). Granulosa cells were isolated from equine chorionic go-
nadotropin (eCG)-primed immature female rats according to the
procedure described elsewhere (Selvaraj and Moudgal, 1994).
The cells were fixed in 1% buffered-paraformaldehyde for 30
minutes at 4C, washed with 1 mL PBS containing glycine (GB-
PBS; 10 mM glycine and 1% BSA) 3 times, and incubated with
50 g IgG equivalent of respective antiserum or normal rabbit
serum (NRS; for nonspecific) for 60 minutes at room tempera-
ture. Cells were washed 3 times using 1 mL GB-PBS each time
following incubation with anti-rabbit IgG coupled with fluores-
cein isothiocyanate (FITC; Sigma) for 30 minutes at room tem-
perature. While the washed granulosa and Leydig cells were re-
suspended in GB-PBS, the green (FITC) fluorescence was mea-
sured using a FACScan flow cytometer equipped with a 15-mw
argon-ion laser at an excitation wave length of 488 nm. The
fluorescence signal for FITC was collected after a 525 band pass
(505–545 nm).
Serum Testosterone Assay
Testosterone in ether-extracted sera was assayed using a well-
standardized and routinely used radioimmunoassay procedure
(Mukku et al, 1981). The sensitivity of the assay was 10 pg/
tube, and the interassay and intraassay coefficients of variation
were 9.3% and 8.3%, respectively.
Data Analysis
The statistical significance was assessed by one-way ANOVA
and the Mann-Whitney t-test. The level of significance was set
at 5%.
Results
Antibody Titration and Characterization
All 3 rabbits responded to immunization by producing
antibodies that bound the LH-RP (Figure 1). They re-
sponded to the booster injection by producing relatively
high antibody titers that were measurable for more than
100 days. The antibody to our synthetic LH-RP21–41 prep-
aration showed complete cross-reaction with LH-RP21–41
preparations obtained from different sources. The anti-
body further cross-reacted with a synthetic LH-RP21–38
preparation and the ED50 of all 4 synthetic preparations
ranged between 1:1000 and 1:1800 (Figure 2).
Western blot analysis was used to demonstrate the in-
teraction of the peptide antibodies with mouse testicular
LH receptor. All 3 rabbits reacted with a major compo-
nent of the mouse testis (Figure 3) with an estimated mo-
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Figure 3. Western blot analysis of mouse testicular extract using the 3
anti-LH receptor antisera. The numbers on top indicate the respective
antisera shown in Figures 1 and 2. In each panel, the lane on the left is
the detergent solubilized testicular extract, and the right shows skeletal
muscle protein. The Mr deduced in comparison to molecular weight mark-
ers is shown on the extreme left. The bottom panel shows the same
blots reprobed with an antibody actin following stripping of the LH recep-
tor antibody. Note that actin intensity is stronger in skeletal muscle.
Figure 4. The representative overlay-histograms of normal rabbit serum
(NRS) and anti-LH-RP bound to (A) rat granulosa cells, (B) rat Leydig
cells, and (C) monkey Leydig cells as determined by immunocytometry.
The x-axis shows the green fluorescence intensity of FITC on log scale
and the y-axis indicates the number of cells per channel (see text for
details).
lecular weight of 77 kilodaltons (kd), equivalent to the
mass of the full-length glycosylated LH receptor predict-
ed by complementary DNA cloning (Loosfelt et al, 1989).
The intensity of the band revealed by each antibody for
the same testicular extract was, however, different, re-
vealing differences in the titer of the antibodies. Some
smaller bands were also apparent, but these were not con-
sistent for all 3 rabbit antisera. Extracts of skeletal muscle
used as a control showed no reaction at the 77-kd region.
Other lighter bands observed are attributable to some mi-
nor, nonspecific reactions. The bottom panel of each blot
shows equivalent protein loading as revealed by the actin
antibody. As expected, the intensity of actin band in skel-
etal muscle is much stronger than in testis.
The ability of the antibody to recognize cell-associated
LH receptor was demonstrated using flow cytometry. The
antibody specifically bound rat granulosa and Leydig
cells, both of which are known to have LH receptors (Fig-
ure 4A and B). The histogram shows that it is possible
to clearly distinguish between the specific binding of the
LH-RP antibody and the nonspecific binding of preim-
mune IgG. The antibody also specifically bound to mon-
key Leydig cells (Figure 4C).
The specificity of the LH-RP antibody was further
checked by determining its ability to inhibit binding of
125I hCG to a particulate sheep luteal LH receptor prepa-
ration. Antiserum of all 3 rabbits exhibited inhibitory ac-
tivity, maximal inhibition in binding of 40%–50% being
observed between days 125–150 of immunization (Figure
5), the time period when the antibody titer was also high
(R 0.93). Nonspecific inhibition observed with an equal
volume of preimmune sera was less than 5%.
Effect of Immunization with LH-RP21–41 on Testicular
Function
During the first 100 days of immunization the serum tes-
tosterone levels (Figure 6) showed a twofold to threefold
increase over the control values (control, 7.8  0.47 ng/
mL vs immunized, 17.38  1.2 ng/mL; P  .0001). This
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Figure 5. Ability of the LH-RP antibody at different times of immunization
to inhibit binding of 125I hCG to a sheep luteal LH receptor preparation
(see text for details). The rabbit numbers 123, 126, and 127 are repre-
sented by symbols , , and H17009, respectively. Note that an equivalent
amount of nonimmune sera obtained from control rabbits inhibited bind-
ing of 125I hCG to the sheep luteal LH receptor preparation to a maximal
extent of 5%.
Figure 6. Effect of LH-RP immunization on serum testosterone levels.
Three rabbits were used in each case. The n in parentheses refers to
the total number of blood samples analyzed from the 3 rabbits during a
particular time interval.
The effect of immunization of rabbits on the distribution pattern of testicular germ cell composition and transformation ratios as determined
by flow cytometry
Day of
Immunization
Percentage of Germ Cells (mean  SEM)
HC 1C 2C S-ph 4C
0
120
300
26.2  2.9
9.3  4.7*
11.4  3.8*
52.4  3.6
37.7  18.9
46.93  7.5
10.6  0.6
39.2  5.6†
17.86  4.7
2.45  0.4
5.39  1.0*
3.9  0.9
4.93  0.2
8.35  1.4
19.8  5.5*
Transformation Ratios (mean  SEM)
HC :2C 1C :2C 1C :4C HC :4C HC :1C
0
120
300
2.76  0.1
0.69  0.3†
0.73  0.4†
4.96  0.7
2.82  1.5
3.32  1.4
10.56  0.8
3.93  2.0*
2.86  0.9†
5.66  0.7
0.94  0.5‡
0.79  0.5‡
0.57  0.008
0.16  0.008‡
0.24  0.007‡
Results of analysis of testicular cell preparations obtained from testicular biopsy samples of the 3 immunized rabbits are provided. At each time
point, 10 000 cells/sample were analyzed by flow cytometry. Each data point is the mean  SEM of 3 rabbits.
HC indicates elongated spermatids; 1C, round spermatids; 2C, spermatogonia and non-germ cells; S-ph, spermatogonial cells synthesizing DNA;
4C, primary spermatocytes.
*  p  .05, †  p  .01 and ‡  p  .0001.
was reminiscent of the hormone agonist activity, observed
when rabbits were immunized with the natural holo sheep
LH receptor protein (Jeyakumar and Moudgal, 1996).
During later periods of immunization (more than 100
days), however, the serum testosterone levels generally
showed marked reduction (by 80%) in its level over con-
trol (immunized, 1.76  0.3 ng/mL vs control, 7.80 
0.47 ng/mL; P  .0001). Because blood samples for assay
were always taken around the same time of the day, the
reduction in testosterone levels cannot be ascribed to any
diurnal variations in serum testosterone levels. Besides,
we had earlier shown that the species of rabbit used in
the current study does not exhibit diurnal rhythms or sea-
sonality (Jeyakumar et al, 1995). We also observed earlier
that immunization of rabbits with a nonspecific protein-
like mouse IgG does not lead to any change in testicular
function (Jeyakumar et al, 1995). The reduction in tes-
tosterone level was observed to negatively correlate with
the increase in hCG receptor binding inhibition activity.
Blockade of LH function with an antibody to LH-RP
may lead to arrest in spermatogenesis. The effect of active
immunization with LH-RP on testicular germ cell trans-
formation was monitored by flow cytometry using a sin-
gle-cell preparation obtained from testicular biopsy ma-
terial taken following 0, 120, and 300 days of immuni-
zation. The percentage of different germ cell types present
was quantified according to a procedure standardized ear-
lier (Suresh et al, 1992). Overall spermatogenesis moni-
tored by quantifying transformation of spermatogonia
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(2C) to elongate (HC) spermatids showed the HC:2C ratio
to be significantly inhibited (75%; P  .01) in all 3 rabbits
at both 120 and 300 days of immunization (Table). This
effect appeared to be due to a block in meiosis as seen
by significant inhibition in the transformation of primary
spermatocytes (4C) to round (1C; P  .05) and elongated
(HC; P  .0001) spermatids (Table). The transformation
of round to elongate spermatids (HC:1C) was also sig-
nificantly (P  .0001) inhibited (Table). Normally, the
cells having a 2C and 4C amount of DNA do not exceed
15%–20% of total germ cells analyzed. However, if mei-
osis is blocked, the percentage of cells having 2C and 4C
amounts of DNA could show a relative but substantial
increase (41%–52%), as in the present case.
Discussion
A primary objective of the current study was to determine
whether we could obtain antibodies capable of interacting
with a natural LH receptor using as the immunogen a
synthetic peptide representing an apparent active site
(Roche et al, 1992) of the LH receptor. High antibody
titer was maintained between 100–250 days of immuni-
zation and its ability to specifically interact with the LH
receptor was established using both in vitro and in vivo
tests. The LH-RP antibody bound 3 preparations of syn-
thetic LH-RP21–41 procured from different sources as well
as an LH-RP21–38 preparation with equal avidity. In West-
ern blot analysis using mouse testicular extract as the pro-
tein source, the antibody of all 3 rabbits showed binding
to a 77-kd protein, a molecular species similar to the
mouse LH receptor. In addition, the antibody of all 3 rab-
bits significantly inhibited the binding of 125I-hCG to a
particulate sheep luteal LH receptor preparation.
The LH-RP antibody and not the preimmune rabbit se-
rum bound granulosa and Leydig cells. The significant
inhibition (40%–50%) in binding of 125I hCG to sheep
luteal receptor obtained with LH-RP antibody is sugges-
tive of the antibody interacting with at least one of the
hCG binding sites in the receptor. In our earlier study, use
of hCG monoclonal antibodies in the binding inhibition
assay had shown that individually, no one agent could
inhibit binding to the receptor by more than 45%. How-
ever, 2 or more monoclonal antibodies added together re-
sulted in close to 80% inhibition, indicating that hCG is
interacting with its receptor through more than one site
(Jeyakumar et al, 1997).
Depending on the period of immunization (early, less
than 100 days vs late, more than 100 days of immuni-
zation), the LH-RP antibody generated by the rabbits ap-
peared to simulate as well as block endogenous LH ac-
tivity. This was reflected by a marked change in serum
testosterone levels, an increase over control levels before
100 days (120% increase; P  .0001), and in a significant
decrease in testosterone levels below the control beyond
100 days (80% decrease; P  .0001). This decrease in
serum testosterone correlated, interestingly, with an in-
crease in the ability of the antibody to block in vitro 125I
hCG binding to the receptor.
There seems to be a distinct difference in the way rab-
bits respond to the holo sheep LH receptor protein and
the rat LH-RP21–41 peptide. In the earlier study on the holo
receptor, serum testosterone level was never suppressed
below control even after prolonged immunization and
consequently, no inhibition of spermatogenesis was ob-
served. This was indicative of the coexistence of LH
mimicking and antagonistic antibodies through the period
of immunization (Jeyakumar and Moudgal, 1996). In the
current study with rat LH-RP21–41 peptide, however, the
serum testosterone concentration as well as spermatogen-
esis were significantly inhibited following prolonged im-
munization. Such effects are expected to follow the block-
ade of LH function. We have shown earlier that immu-
nization of male rabbits with the hormone ovine LH re-
sults in significant reduction in serum testosterone levels,
leading to blockade of meiosis and consequently, sper-
matogenesis (Jeyakumar et al, 1995). A similar observa-
tion was also made using a different approach altogether,
such as the use of norethisterone as a feedback inhibitor
of LH secretion (Suresh et al, 1995; Shetty et al, 1997).
In conclusion, it appears from the foregoing that the
synthetic LH-RP peptide used in the current study rep-
resents a functional receptor binding site and can supplant
the holo LH receptor as an effective immunogen in any
future vaccine study. By blocking even one of several
receptor binding sites of hCG with the LH-RP antibody
we were able to obtain substantial suppression of in vivo
LH function. Whether it is possible to completely elimi-
nate hormone-mimicking activity by synthesizing ana-
logues of this peptide remains to be determined, as they
may prove to be useful therapeutic agents.
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